Glimisave MV 1mg/500mg/0.3mg Tablet
Manufacturer
Eris Lifesciences Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Key Information
Short Description
Glimisave MV 1mg/500mg/0.3mg Tablet is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Dosage Form
Tablet
Introduction
Glimisave MV 1mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimisave MV 1mg/500mg/0.3mg Tablet is to be taken empty stomach.
How it works
Glimisave MV 1mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines:
Quick Tips
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Related Medicines
Vogs GM 1mg/500mg/0.3mg Tablet
Gliminyle MV 1 Plus Tablet
Tagg MV 1mg/500mg/0.3mg Tablet
Glucolive MV 1mg/500mg/0.3mg Tablet
Vokem GM 1mg/500mg/0.3mg Tablet
Tripride 1 HV Tablet
Glimitos MV 1mg/500mg/0.3mg Tablet
Glimitos MV Tablet
Voglimust MF 1mg/500mg/0.3mg Tablet
Glumight MV 1mg/500mg/0.3mg Tablet
Frequently asked questions
What is Glimisave MV 1mg/500mg/0.3mg Tablet?
Glimisave MV 1mg/500mg/0.3mg Tablet is a combination of three active ingredients: Glimepiride, Metformin and Voglibose. This medication is prescribed for the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken alongside a healthy diet and regular exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas. Metformin reduces glucose production in the liver and enhances insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, lowers postprandial (after meal) glucose levels.
What are the possible side effects of Glimisave MV 1mg/500mg/0.3mg Tablet?
Common side effects associated with Glimisave MV 1mg/500mg/0.3mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
Are there any specific conditions under which Glimisave MV 1mg/500mg/0.3mg Tablet should not be taken?
Avoid using Glimisave MV 1mg/500mg/0.3mg Tablet if you are allergic to any of its components or excipients. This medicine should also not be used in patients with moderate to severe kidney disease, inflammatory bowel disease (IBD), colonic ulcers, and underlying metabolic acidosis including diabetic ketoacidosis.
Is it safe to take alcohol while I am also taking Glimisave MV 1mg/500mg/0.3mg Tablet?
No, combining alcohol with Glimisave MV 1mg/500mg/0.3mg Tablet is not recommended. It may lead to lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Can the use of Glimisave MV 1mg/500mg/0.3mg Tablet cause hypoglycemia?
Yes, Glimisave MV 1mg/500mg/0.3mg Tablet can induce hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. These symptoms are often more frequent if you miss or delay meals, consume alcohol, over-exercise, or take other antidiabetic medications simultaneously. Regular monitoring of blood glucose levels is vital. Always keep glucose tablets, honey, or fruit juice readily available.
What are the instructions for the storage and disposal of Glimisave MV 1mg/500mg/0.3mg Tablet?
Store this medicine in its original packaging, tightly sealed. Follow the instructions provided on the label. Never discard unused medication and ensure it is not accessible by pets, children, or other individuals.
